United States· US:0220-9095_fb5a86ae-243a-f9a0-e053-6394a90a504b
DIARALIA
A medicinal product containing podophyllum; cinchona officinalis bark; arsenic trioxide, registered in United States by BOIRON.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PODOPHYLLUM; CINCHONA OFFICINALIS BARK; ARSENIC TRIOXIDE
- Manufacturer
- BOIRON
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11022090950460 BLISTER PACK in 1 CARTON (0220-9095-04) / 60 TABLET in 1 BLISTER PACK
- ndc110220-9095-04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5054a90-d9a8-4254-a251-1028694363a7 GET /v1/drugs/f5054a90-d9a8-4254-a251-1028694363a7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "9; 5; 9",
"substance": "PODOPHYLLUM; CINCHONA OFFICINALIS BARK; ARSENIC TRIOXIDE",
"productndc": "0220-9095",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/1; [hp_C]/1; [hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about podophyllum; cinchona officinalis bark; arsenic trioxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.